Engineering thrombin to function as a selective anticoagulant by identification of a Glu to Lys mutation that converts thrombin into an exclusive protein C activator. Tsiang, M., Li, W. X., Jain, A. K., Mao, C. T., Dunn, K. E., MATSUMURA, S. Y., Coutre, S., Leung, L. L., Paborsky, L. R., Gibbs, C. S. AMER SOC HEMATOLOGY. 1995: 1779–79

View details for Web of Science ID A1995TH91001781